Zymeworks Outlines Strategic Priorities and Outlook for 2026

GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) ...
Shanghai Metals Market

Heyuan Lithium Innovation's Solid-State Battery Layout—Mass Production and Delivery of "Liuhe Battery" with Multiple Production Capacity Plans

On January 10, 2026, Heyuan Lithium Innovation's Huaian base, the first dedicated solid-state battery mass production base in ...

Zymeworks Inc.: Zymeworks Outlines Strategic Priorities and Outlook for 2026

Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
NJBIZOpinion

OPINION: How New Jersey is leading AI innovation in life sciences

New Jersey is emerging as a national leader in AI-driven life sciences, transforming health care, drug discovery and ...
The Manila Times

Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs and Extends its Opera…

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...

Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs and Extends its Operating ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...